Y-mAbs Therapeutics, Inc. Other Accrued Liabilities, Current
Y-mAbs Therapeutics, Inc. had Other Accrued Liabilities, Current of $633.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2025-08-08
- 2025-06-30: Other Accrued Liabilities, Current $633.00K.
- 2025-03-31: Other Accrued Liabilities, Current $923.00K.
- 2024-12-31: Other Accrued Liabilities, Current $826.00K.
- 2024-09-30: Other Accrued Liabilities, Current $1.31M.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2025-06-30 | $633.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $923.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $826.00K 10-Q · filed 2025-08-08 |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $772.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $713.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $419.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $745.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $450.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $319.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $411.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.52M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $273.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.44M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.42M 10-K · filed 2023-03-30 |
| 2021-09-30 | $642.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $998.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $995.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $325.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $335.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $198.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $401.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $377.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $2.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $272.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $380.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $525.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $395.00K 10-Q · filed 2018-11-13 |
| 2017-12-31 | $119.00K 10-K · filed 2019-03-22 |